Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan

被引：32

作者：

Akuta, Norio ^{[1
,2
]}

Kawamura, Yusuke ^{[1
,2
]}

Arase, Yasuji ^{[1
,2
]}

Saitoh, Satoshi ^{[1
,2
]}

Fujiyama, Shunichiro ^{[1
,2
]}

Sezaki, Hitomi ^{[1
,2
]}

Hosaka, Tetsuya ^{[1
,2
]}

Kobayashi, Masahiro ^{[1
,2
]}

Kobayashi, Mariko ^{[3
]}

Suzuki, Yoshiyuki ^{[1
,2
]}

Suzuki, Fumitaka ^{[1
,2
]}

Ikeda, Kenji ^{[1
,2
]}

Kumada, Hiromitsu ^{[1
,2
]}

机构：

[1] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, 2-2-2 Toranomon, Tokyo 1050001, Japan

[2] Okinaka Mem Inst Med Res, Minato Ku, 2-2-2 Toranomon, Tokyo 1050001, Japan

[3] Toranomon Gen Hosp, Liver Res Lab, Tokyo, Japan

来源：

BMC GASTROENTEROLOGY | 2018年 / 18卷

关键词：

Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Hepatocellular carcinoma; Liver-related events; Cardiovascular events; Type 2 diabetes mellitus; Malignancy; Mortality; Fibrosis stage; Hepatocyte steatosis; NONALCOHOLIC STEATOHEPATITIS; FIBROSIS STAGE; FOLLOW-UP; DISEASE; MORTALITY; BIOPSY; DIAGNOSIS; RISK;

D O I：

10.1186/s12876-018-0900-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

BackgroundThe incidence of liver-related events, cardiovascular events and type 2 diabetes mellitus in patients with histopathologically confirmed NAFLD remains unclear.MethodsWe retrospectively investigated the incidence of liver events, cardiovascular events, malignancy, and type 2 diabetes mellitus in 402 Japanese patients with histopathologically confirmed NAFLD for a median follow-up of 4.2years. We also investigated predictors of the development of hepatocellular carcinoma and type 2 diabetes mellitus in these patients.ResultsThe rate of liver-related events per 1000 person years was 4.17 (hepatocellular carcinoma, 3.67; hepatic encephalopathy, 1.60; esophago-gastric varices, 2.43; ascites, 0.80; and jaundice, 0.40). The rate of cardiovascular events and type 2 diabetes mellitus was 5.73 and 9.95, respectively. Overall mortality was 3.33 (liver-related events, 1.25; cardiovascular events, 0.42; and malignancies other than hepatocellular carcinoma, 0.83), in patients free of previous or current malignancies. Multivariate analyses identified old age (70years) and advanced fibrosis stage 4 as significant determinants of hepatocellular carcinoma development, and hepatocyte steatosis (>33%), female sex, and serum ferritin (80g/l) as significant determinants of type 2 diabetes mellitus development in these patients.ConclusionsOur results highlighted the importance of cardiovascular and liver-related events in Japanese patients with histopathologically-confirmed NAFLD. Hepatocellular carcinoma was the most common liver-related event, and the incidence of hepatocellular carcinoma was more than half of that of cardiovascular events.

引用

页数：10

共 24 条

[1] Effects of a Sodium-Glucose Cotransporter 2 Inhibitor in Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus: Preliminary Prospective Study Based On Serial Liver Biopsies [J].

Akuta, Norio ;

Watanabe, Chizuru ;

Kawamura, Yusuke ;

Arase, Yasuji ;

Saitoh, Satoshi ;

Fujiyama, Shunichiro ;

Sezaki, Hitomi ;

Hosaka, Tetsuya ;

Kobayashi, Masahiro ;

Kobayashi, Mariko ;

Suzuki, Yoshiyuki ;

Suzuki, Fumitaka ;

Ikeda, Kenji ;

Kumada, Hiromitsu .

HEPATOLOGY COMMUNICATIONS, 2017, 1 (01) :46-52

[2] Nonalcoholic fatty liver disease [J].

Brunt, Elizabeth M. ;

Wong, Vincent W. -S. ;

Nobili, Valerio ;

Day, Christopher P. ;

Sookoian, Silvia ;

Maher, Jacquelyn J. ;

Bugianesi, Elisabetta ;

Sirlin, Claude B. ;

Neuschwander-Tetri, BrentA. ;

Rinella, Mary E. .

NATURE REVIEWS DISEASE PRIMERS, 2015, 1

[3] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].

Angulo, Paul ;

Kleiner, David E. ;

Dam-Larsen, Sanne ;

Adams, Leon A. ;

Bjornsson, Einar S. ;

Charatcharoenwitthaya, Phunchai ;

Mills, Peter R. ;

Keach, Jill C. ;

Lafferty, Heather D. ;

Stahler, Alisha ;

Haflidadottir, Svanhildur ;

Bendtsen, Flemming .

GASTROENTEROLOGY, 2015, 149 (02) :389-+

[4]

[Anonymous], HEPATOL RES

[5] Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients [J].

Arase, Yasuji ;

Kobayashi, Mariko ;

Suzuki, Fumitaka ;

Suzuki, Yoshiyuki ;

Kawamura, Yusuke ;

Akuta, Norio ;

Imai, Norihiro ;

Kobayashi, Masahiro ;

Sezaki, Hitomi ;

Matsumoto, Naoki ;

Saito, Satoshi ;

Hosaka, Tetsuya ;

Ikeda, Kenji ;

Kumada, Hiromitsu ;

Ohmoto, Yuki ;

Amakawa, Kazuhisa ;

Hsieh, Shiun Dong ;

Ogawa, Kyoko ;

Tanabe, Maho ;

Tsuji, Hiroshi ;

Kobayashi, Tetsuro .

HEPATOLOGY RESEARCH, 2012, 42 (03) :264-272

[6] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].

Armstrong, Matthew James ;

Gaunt, Piers ;

Aithal, Guruprasad P. ;

Barton, Darren ;

Hull, Diana ;

Parker, Richard ;

Hazlehurst, Jonathan M. ;

Guo, Kathy ;

Abouda, George ;

Aldersley, Mark A. ;

Stocken, Deborah ;

Gough, Stephen C. ;

Tomlinson, Jeremy W. ;

Brown, Rachel M. ;

Huebscher, Stefan G. ;

Newsome, Philip N. .

LANCET, 2016, 387 (10019) :679-690

[7] Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease [J].

Bedossa, Pierre .

HEPATOLOGY, 2014, 60 (02) :565-575

[8] Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease [J].

Bjorkstrom, Karl ;

Stal, Per ;

Hultcrantz, Rolf ;

Hagstrom, Hannes .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (09) :1461-1468

[9]

Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x

[10] Surveillance for Hepatocellular Carcinoma [J].

Della Corte, Cristina ;

Colombo, Massimo .

SEMINARS IN ONCOLOGY, 2012, 39 (04) :384-398

← 1 2 3 →